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INTRODUCTION
This review will examine the effects of advanced
physiological aging on gastrointestinal (GI) neuromus-
cular anatomy and function. We will emphasize con-
tributions from the past several years, and build-upon
the excellent reviews of Camilleri et al. and Bitar and
Patil.1,2 We will not include references to early devel-
opmental changes in the enteric nervous system (ENS).
We will begin with a review of our current under-
standing of the effects of advanced age in the human GI
tract and use these observations as a foundation to
examine potentially relevant mechanisms underlying
physiological aging. Using data from animal models,
we have included references to mechanistically driven
studies that focus on extraintestinal sites where we
consider that these observations have relevance to physio-
logical aging involving GI neuromuscular function.
EFFECT OF AGING ON GI
NEUROMUSCULAR FUNCTION IN THE
HUMAN
Background
In the absence of systemic diseases that are often
associated with the use of medications that can affect
the brain–gut axis, clinically significant changes in the
brain–gut axis are typically not apparent prior to the
seventh decade of life.3 Alterations in taste and smell,
gastric motility, increased presence in bacterial intes-
tinal overgrowth and changes in GI hormone and
neurotransmitter levels may contribute to physiologi-
cal anorexia observed in advanced age. Alterations in
swallowing leading to silent aspiration, as well as
changes in gastric emptying may contribute to post-
prandial hypotension and maldigestion. Age-related
alterations in the structure and function of the pelvic
floor and anorectum may be a major contributor to the
constipation and fecal incontinence encountered in the
elderly, and age-associated weakening of the colonic
muscular wall may contribute to the development of
diverticulosis.4 Finally, the clinical impact of co-mor-
bid conditions such as cardiovascular disease, hyper-
tension and diabetes mellitus, and their treatment are
likely to have a significant effect on GI neuromuscular
function but this issue remains undefined.5
Motor and sensory changes in the oropharynx
Dysphagia and anorexia are common complaints in
the elderly which may be in part related to the
changes in motor and sensory function of the oro-
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pharynx. Aging has been reported to affect pharyngeal
persistalsis, upper esophageal sphincter opening, supr-
ahyoid muscle contraction, and deglutitive excursion
of the larynx and hyoid bone which are believed to be
contributors to the alteration in bolus kinematics and
dynamics of pharyngeal swallowing in the elderly.6
Dejaeger et al. demonstrated that a reduction in the
driving force of the tongue, decrease in amplitude of
the pharyngeal wall contraction and reduction in
pharyngeal swallowing occur in the elderly contrib-
uting to the retention of food in the valleculae and
piriform sinuses.7 A decrease in the afferent arm of
the laryngo-upper esophageal sphincter reflex has
been demonstrated to occur with age, which may
also be a contributor to the development of dyspha-
gia.8 The gag reflex has been reported to be absent in
40% of healthy elderly adults.9 It has been proposed
that the deterioration in sensations of taste, smell and
vision seen in the elderly be a factor to the common
complaint of anorexia reported in this age group.10
Motor and sensory changes in the esophagus
Similarly, the changes in esophageal motor and sensory
function may contribute to the dysphagia, reflex
symptoms and anorexia commonly reported by the
elderly. Earlier studies have consistently demonstrated
a reduction in esophageal peristalsis and increase in
non-propulsive contractions, and to lesser degree,
a reduction in lower esophageal sphincter (LES)
pressure.11,12 A recent study by Gregersen et al. using
manometric swallow analysis with a distention method
demonstrated decreased compliance of the esophagus
with age as well as a deterioration of the active
contractile properties of the esophagus.13 This study
also reaffirmed a reduction in primary as well as
secondary esophageal peristalsis with age. Aged-related
increases in esophageal motor abnormalities appears to
have a significant clinical impact based on an review of
452 clinical manometric studies performed at an
Australia tertiary care center.14 Similarly, a large
retrospective study of patients referred for reflux
symptoms demonstrated an age-related decrease in
LES length and esophageal motility.15 There is also
evidence suggesting that the aged esophagus is less
likely to sense acid reflux. 15
Motor and sensory changes in the stomach
The available literature is inconsistent regarding the
effects of aging on gastric motor function. Several
small studies have reported conflicting data on gastric
emptying times.11,12,16 The largest study to date
involving 172 healthy patients demonstrated a trend
towards slowing in gastric emptying by an average of
6 min for every 10 years of increase in age.17 Other
observed gastric motor changes with aging include a
reduction in postprandial peristalsis and gastric con-
tractile force.18 However, whether these motor changes
have any role in the increased prevalence of anorexia
and dyspeptic symptoms reported in the elderly
remains to be determined. There are no reported
gastric sensory changes associated with aging.
Motor and sensory changes in the small bowel
The sensory and motor function of the small bowel
appear well preserved aside from minor manometric
effects reported to include decreased frequency of
postprandial contraction, the migrating motor complex
(MMC) and propagated clustered contractions.5 In the
small bowel the overall motility patterns and transit
time have been reported as unchanged from those of
younger adults.12,19 However, a recent multicenter trial
of 172 healthy adults using a wireless motility capsule
reported a statistically significant decrease in small
bowel transit time with aging by an average of 12 min
for every 10 years of increase in age.17 Although similar
findings have been reported by Graff et al.20 an expla-
nation for this finding remains unclear but may repre-
sent a phenomenon related to increased prevalence of
small bowel bacterial overgrowth in the elderly.
Motor and sensory changes in the colon
Although the incidence of constipation increases con-
siderably with aging, the effects of aging on colonic
motility and colonic transit time appear less clear.
Some earlier studies report a prolongation in colon
transit time with aging, whereas more recent studies
observed no change in transit time with aging.12,17,21
A reduction in the propulsive efficacy has been
reported; however, this does not appear to translate
into any clinically significant outcome.11,22 There are
no reported aged-related changes in the sensation of the
human colon excluding the rectum which is reviewed
below.
Motor and sensory changes in the anorectum
Much like the proximal GI tract, aging has a consid-
erable effect on the motor and sensory function of the
anorectum. Although there are studies with discrepant
findings, the preponderance of published studies report
age-related reduction in basal and maximum anal
sphincter tone, decreased compliance of the rectal
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vault and increased perineal descent.5,12,19,22 These
age-related changes are more pronounced in women
compared to men and there is speculation that vaginal
childbirth may play a role in this observation. Aging is
also associated with altered rectal sensation. Most
studies demonstrate rectal hypersensitivity but other
studies observed reduced rectal sensation.5,12,19,22
These alterations in anorectal function are generally
thought to contribute significantly to the constipation
and fecal incontinence reported in the elderly. What
remains less clear is whether these changes in ano-
rectal function are a result of the aging process itself or
due to other factors such as trauma related to child
delivery or other co-morbidities associated with neu-
rodegenerative effects involving the pelvic floor.21
In summary, the age-related changes in motor and
sensory function of the human gut appear most
pronounced and best defined in the proximal and distal
portions of the GI tract. This may be result of the
greater role of skeletal muscle in the function in these
regions of the GI tract. This may also be due to the
relative ease in assessing motor and sensory functions
of the proximal and distal GI tract in comparison with
other areas of the gut. A variety of changes have been
reported in other areas of the GI tract. The inconsis-
tencies regarding some age-related changes in GI motor
function likely reflect differences in experimental
design regarding patient selection and the methods
used to assess motor and sensory function.
AGING AND GI EXTRINSIC AND
INTRINSIC NEURAL PATHWAYS
There are numerous animal studies showing that
aging has significant effects on nerves at both a
supraspinal and peripheral level. Advanced age is
associated with reduced neurotransmitter content and
expression and there is a substantial loss of neurons
and dendritic connections throughout the cerebral
cortex, midbrain and brainstem.23 Aging has also been
found to significantly affect the spinal cord and age-
related changes have been measured in neurotrans-
mitter content and receptor expression within the
spinal cord. Specifically, it has been shown that spinal
levels of calcitonin gene-related peptide (CGRP) and
substance P (SP) are decreased in aged rats compared
to younger animals, as is the expression of dopamine
and serotonin receptors.24,25 In contrast to the paucity
of information on the effect of aging on the extrinsic
control of the GI tract, more information is available
regarding the effect of aging on the ENS, though most
of this data have been obtained from rodents. Age-
associated decrease in the number of enteric neurons
has been implicated in several studies. For example,
Phillips et al. found that neuron loss occurs in the
myenteric plexus of the aged rat.26 Specifically, age-
related cell loss in the small and large intestines
occurred exclusively in the cholinergic subpopulation
but based on the presence of somatic hypertrophy and
swollen axons that nitrergic neurons were not com-
pletely spared from the effects of age.
Kasparek et al. studied age-related changes in non-
adrenergic, non-cholinergic (NANC) VIP and SP func-
tion in the jejunum of young (age 3 months) and
middle age (age 15 months) Lewis rats. In the jejunum
of middle-aged rats, participation of VIP in functional
NANC innervation was increased, while functional
innervation with SP was decreased supporting age-
associated plasticity in neuromuscular bowel func-
tion.27 Peck et al. examined the guinea-pig colon for
age-associated changes in gut dimensions, myenteric
neuron size, density, ganglionic area and motor nerve
fibers in the circular muscle layer in the guinea pig.28
The density of myenteric neurons in mid-colon
decreased by 50% from 2 weeks to 2 years, but when
the increase in colon dimensions was considered, the
number of neurons decreased by 20%. Finally, the
percentage area of motor nerve fibers in the circular
muscle decreased with no change in the total volume
of nerve fibers. Thus, advanced age appeared to be
associated with a fall in density but not the number of
myenteric neurons and circular muscle fibers.
There is limited data examining the effect of aging
on the innervation of the human GI tract. Hanani et al.
investigated the effect of aging on the structure of
myenteric ganglia in the human colon in patients aged
10 days to 91 years.29 Myenteric ganglia were classified
into three types: normal, those containing empty
spaces (cavities) and those containing large nerve fiber
bundles. Aging was associated with a significant
increase in the proportion of ganglia with cavities.
Conversely, there was a decrease with age in the
proportion of normal ganglia and the proportion of
fiber-containing ganglia did not change with age.
Therefore, advanced age was associated with an
increase in the number of abnormal appearing myen-
teric ganglia in the human colon. Bernard et al. studied
age-associated (age 33–99 years old) changes in the
number, subtypes of enteric neurons and neuronal
volumes in normal human descending and sigmoid
colon.30 Neuronal markers included HuC/D, choline
acetyltransferase (ChAT), neuronal nitric oxide syn-
thase (nNOS) and protein gene product 9.5. The
number of neurons in the colon declined with age,
although nNOS-positive neurons were spared. Of
interest, these alterations were not accompanied by
K. Bitar et al. Neurogastroenterology and Motility
 2011 Blackwell Publishing Ltd492
changes in total volume of neuronal structures sup-
porting the presence of compensatory changes in the
remaining neural population. At the peripheral level,
loss in myelinated and unmyelinated nerve fibers,
axonal atrophy and abnormalities in nerve conduction
have been reported.31 In summary, available data
suggest that advanced age likely has differential effects
on subpopulations of neurons in the ENS which
demonstrate regional- and species-specific differences.
AGE-RELATED CHANGES IN THE NEURAL
CONTROL OF THE GI MUSCULATURE
Some neurological disorders can be associated with
severe constipation and provide insight regarding
potential mechanisms underlying age-associated neu-
rodegeneration in the gut. For example, constipation is
common complaint in patients with Parkinson’s dis-
ease (PD).32 Although PD is a progressive neurodegen-
erative disorder of dopamine-containing neurons in the
substantia nigra, there is evidence to suggest that
neuronal structures outside the brain are affected by
the neurodegenerative process of PD. Recent reports
using colonic biopsies from patients with PD have
shown that ENS lesions are apparent. Interestingly,
these studies show that the ENS abnormalities are
observed during early stages of the disease and may even
precede the onset of neuronal damage in the brain.33,34
Supporting these clinical observations, recent data
obtained in rodent models of PD have been instrumen-
tal in increasing our understanding of the changes in the
neural innervation of the gut associated with PD. For
example, in models of PD induced by the prototypical
Parkinsonium neurotoxin MPTP (1-methyl 4-phenyl
1,2,3,6-tetrahydropyridine), the loss of enteric dopami-
nergic neurons is associated with abnormal colonic
contractility leading to a marked inhibition of propul-
sive GI motility and daily fecal pellet output.35,36
Although the loss of dopaminergic neurons in the
ENS may be one of the causes of constipation in PD, the
presynaptic protein a-synuclein, a major component of
Lewy bodies, has also been implicated in changes in the
ENS in PD. Supporting the hypothesis that constipation
in PD is related to abnormal levels of a-synuclein in the
gut, experiments in mice over-expressing human wild-
type a-synuclein, demonstrate abnormal patterns of
colonic motility including increased time to expel an
intracolonic bead compared to wild type mice.37
Although there is increasing scientific and clinical
evidence to support a link between PD and constipa-
tion, there are no data on whether other neurodegener-
ative diseases that affect central neural structures also
alter the innervation of the gut.
It is noteworthy that accumulation of a-synuclein
immunopositive aggregates has also been reported in
the myenteric plexus of the aged rat independent of
PD.38 Alpha-synuclein is abundant throughout the
myenteric plexus but appears to be a protein which is
prone to fibrillization and, therefore, a candidate
marker for age-related axonopathies. Alpha-synuclein-
positive dystrophic axons and terminals were present
throughout the GI tract of middle-aged and aged rats.
However, other dystrophic neurites were not co-reac-
tive for a-synuclein. In addition, a subpopulation of
a-synuclein inclusions contained deposits that immu-
nostained with an anti-s phospho-specific antibody,
but not all of these hyperphosphorylated s-positive
aggregates co-localized with a-synuclein. Therefore,
the presence of heteroplastic and potentially degener-
ating neural elements and protein aggregates both
positive and negative for a-synuclein suggest a complex
chronological relationship between the onset of degen-
erative changes and the accumulation of misfolded
proteins in the myenteric plexus.
The observation that cholinergic neurons innervat-
ing the gut are markedly altered in aged animals points
to a possible enteric neurodegeneration that may
mirror certain aspects of Alzheimer’s disease observed
in the central nervous system.39 However, a link
between the overt neurodegeneration associated with
Alzheimer’s disease and enteric neuronal degeneration
is lacking in part due to the paucity of relevant animal
models and clear clinical evidence from patients with
Alzheimer’s disease.
AGE-RELATED CHANGES IN THE
SUBMUCUS PLEXUS
The submucus plexus (SMP) innervating the GI
mucosa is also likely to be affected in advanced age.
The SMP of the large intestine plays important roles in
secretion and motility, functions that are compromised
in the aged. Phillips et al. examined the effects of aging
on intrinsic SMP neurons and their extrinsic inputs in
the colon of male Fischer 344 rats ranging in age from 6
to 27 months.40 Tissues were processed to visualize
neurons and nerve fibers immunoreactive for either
tyrosine hydroxylase (TH-IR) or calcitonin gene-related
peptide (CGRP-IR). Significant age-related loss of SMP
neurons occurred as early as 12 months of age and
progressed in a roughly linear manner with age,
decreasing by 38% in the distal colon. In the oldest
rats, the colonic SMP routinely contained markedly
swollen TH-IR axons and terminals and exhibited a
reduction of ganglionic neuropil, whereas CGRP-IR
fibers demonstrated only modest axonopathies. These
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observations support selective neural deterioration in
the SMP and its extrinsic inputs.
AGING AND VISCERAL SENSITIVITY
Complaints consistent with irritable bowel syndrome
(IBS) including abdominal pain and abnormal bowel
habits are common in the elderly.41 Although it is
documented that somatic pain sensitivity changes with
advancing age, the effect of aging on visceral pain of GI
origin is a largely neglected area. In one study, a decrease
in esophageal pain perception to graded intraesophageal
balloon distension was observed in older (mean age
72.5 years) individuals compared to younger controls.42
Moreover, Lagier et al. found that rectal sensitivity
thresholds induced by distension were increased in aged
healthy human volunteers.43 However, in the same
study colorectal smooth muscle compliance and tone
were unaffected by aging. The underlying mechanisms
responsible for this impairment of visceral perception in
older people remain unknown. However, it is plausible
that visceral afferents, including nociceptors and noci-
ceptive pathways are vulnerable to age-related changes
or alternatively that abnormalities in the central pro-
cessing of visceral information may be the culprit. To
explore the mechanism(s) underlying the age-related
changes in pain, animal studies suggest that thermal
pain, which is Ad dependent, is very susceptible to aging
whereas C fiber sensory function is relatively unaffected
by aging.44 Furthermore, in senescence-accelerated
mouse models there were significant differences in
nociceptive sensitivities in a battery of somatic pain
tests.45 The consequences of a reduction in visceral
pain perception due to aging on health care delivery
have been reviewed by Moore and Clinch and include
delayed diagnosis, more severe complications and
longer hospital stays.46
AGING AND INTERSTITIAL CELLS OF
CAJAL
Together with enteric nerves and smooth muscle cells,
interstitial cells of Cajal (ICC) play a pivotal role as the
‘pacemakers’ in the control of GI motility. However,
little is known about the effect of aging on ICC.
Gomez-Pinilla et al. examined the effect of aging on
ICC number and volume in the human stomach and
colon.47 In both stomach and colon, the number of ICC
bodies and volume significantly decreased with age at a
rate of 13% per decade. Interstitial cells of Cajal size
was only affected in the myenteric plexus in the colon.
The changes associated with age were not differentially
affected by sex or colonic region. This decrease in ICC
may reduce the functional capacity of the GI motor
apparatus and contribute to changes in GI motility
with aging, as well as, influence intestinal response to
disease, operative interventions and medications in
older patients.
AGING AND INTESTINAL GLIAL CELLS
Glial cells which support the myenteric plexus are also
likely affected by aging.48 Significant reductions in
both the numbers of glia and neurons occurred in every
region of the small and large intestine sampled from
aged rats, except for the rectum, where a non-signifi-
cant decrease was observed. Glial loss was proportional
to neuronal death, supporting an interdependency
between the two cell types.
NEUROGENESIS AND
NEUROPROTECTION IN THE GI TRACT
The ENS has been shown to retain neural crest stem
cells in the adult gut.49 However, the postnatal gut
stem cells demonstrate reduced neuronal subtype
potential. The first demonstration of enteric neurogen-
esis came from recent work by Gershon et al.who
observed that 5HT4 receptor agonists promote enteric
neural development and even neuronal cell survival.
Furthermore, the age-dependent slowing of colonic
transit is more marked in 5HT4 )/) mice suggesting
that 5-HT may have a neural protective role in the
mouse colon.50
AGING AND GI SMOOTH MUSCLE
The role of smooth muscle in the wall of hollow organs
of the GI tract is to maintain organ dimensions and
force development. Both functions contribute to the
role of smooth muscle in modulating the ‘reservoir’
capacity and ‘propulsion’ of food along the length of the
GI tract. Smooth muscle cell (SMC) functionality is
regulated by neurogenic and myogenic components.
Age-dependent changes are observed both in the cho-
linergic neurotransmission as well as the response of
smooth muscle to acetylcholine (Ach). Age-dependent
decrease in agonist-induced contraction is attributed to
impairment in signal transduction pathway(s) in GI
smooth muscle.
Effect of aging on mechanisms of contraction of
circular smooth muscle of the gut
Among the various biological functions affected by
aging is the control of motility of the gut. Colonic
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motility regulated by the smooth muscle contraction
and relaxation cycle, declines with aging.2,51 Colon
tissue from aged mice (24–33 months) showed very
rapid and prolonged VIP-induced relaxation with slow
recovery to baseline force. Furthermore, aged mice also
exhibited delayed and reduced magnitude of Ach-
induced force generation. Altered contractile and
relaxation response in muscle preparations from aged
rodents is due to impairment in regulation of smooth
muscle contraction/relaxation cycle. Studies have
shown that circular smooth muscle preparations from
aged rats had reduced translocation of protein kinase C
(PKC)a and RhoA (member of the Rho family of
GTPases) in response to contractile agonist. Translo-
cation, docking and activation of PKCa is affected in
aging,52 though the expression of PKCa is not. There-
fore, a crucial mechanism involved in PKC transloca-
tion and activation (phosphorylation) is disrupted in
aging. A ‘positive loop’ involving heat shock protein
(HSP)27 is an important mechanism involved in PKCa
translocation and contraction that is affected in aging.
Reduced expression of caveolin (cav)-1 is observed in
aging resulting in reduced translocation and docking of
PKCa. In addition, a decrease in Ach-induced phos-
phorylation of MYPT was observed in SMC from aged
rat which possibly is due to age-related reduction in
translocation of RhoA resulting in reduced activation
of Rho-dependent kinase (ROCK). This leads to
decreased phosphorylation of MLC20 leading to
reduced contraction53 as exhibited in the aged rats.54
Furthermore, aged rat SMC showed decreased Ach-
induced (i) phosphorylation of HSP27, (ii) association of
actin with myosin, and (iii) association of tropomyosin
with HSP27.55
Chaperone proteins such as HSP27 are crucial to
regulate protein conformation, and are essential to
protect proteins from misfolding under normal condi-
tions and when cells are exposed to stress.56 The role
of small heat shock proteins (sHSPs) in aging has
been published by different groups.57,58 For example
over-expression of Drosophila melanogaster HSP22
(DmHsp22) in motor neurons resulted in a 30%
increase in mean lifespan and an increase in resistance
to heat and oxidative stresses. Interestingly, flies over
expressing DmHsp22 kept their locomotors activity/
fitness for longer and flies which do not express
DmHsp22 were more sensitive to stress with decreased
life span.57 Most importantly, DmHsp22 has been also
shown to have an effect on human fibroblast by
extending their lifespan.59 In addition, in the worm
Caenorhabditis elegans, HSP16 has been shown to
promote longevity by being co-activated by transcrip-
tion factor (HSF1) and Daf-16.60 Since several studies
have shown a critical role of small heat shock proteins
in aging, it will be important to analyze the mecha-
nism and regulation of sHSPs during aging.
Restoration of smooth muscle contraction by
reinstatement of signaling pathways
Ectopic expression of cav-1 as well as phosphorylated
HSP27 in aged SMC reinstates smooth muscle con-
traction and force generation.52 Ectopic expression of
cav-1 mediates restoration of PKCa and RhoA signaling
pathways while ectopic expression of phospho-HSP27
reinstates association of contractile proteins as well as
PKCa-mediated signaling pathway.53
Aged transgenic mice that express phosphomimic
HSP27 exhibited regular colonic motor function. Colon
tissue from aged transgenic mice showed no changes in
the expression levels of contractile associated proteins
such as HSP27, HSP20, tropomyosin or caldesmon.
However, there was a significant increase in Ach-
induced phosphorylation of myosin light chain in
CSMC from aged (24–32 months) transgenic mice.
Colon tissue from aged transgenic mice expressing
phosphomimic HSP27 showed reinstatement of adult-
like contraction and relaxation pattern. The data
suggest that reinstatement of phosphorylated HSP27
in CSMC from aged animals resulted in restoration of
contraction and relaxation response similar to the
adult.
Aging and altered endocrine/paracrine regulation
in smooth muscle cells
Growth factors are involved in proliferation and
differentiation of smooth muscle cells originating from
a variety of tissues, including the vasculature and the
airways.61 Deletion of growth hormone (GH) receptors
or GH (alone or along with other pituitary hormones)
produces secondary suppression of circulating IGF-1
and insulin, robust extension of both median and
maximal lifespan as well as numerous indications of
delayed and/or slower aging. Direct targeting of insu-
lin-like growth factor-1 (IGF-1) signaling can also
extend longevity.62 Caloric restriction has been well
accepted to delay aging and prolong life. Caloric
restriction decreases serum IGF-1 concentration by
40%, protects against cancer and slows aging in
rodents.
Several growth factors have been shown to induce a
concentration-dependent contraction and to be poten-
tial inducers of contractile mediator release.63 The
mechanism by which growth factors induce contrac-
tion has only been partly elucidated. IGF-1 is one such
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growth factor whose effect on smooth muscle contrac-
tion has been studied extensively. IGF-1 is a mechano-
growth factor produced primarily by liver as an endo-
crine hormone as well as in target tissues in a
paracrine/autocrine fashion. Recent evidence shows
that IGF-1-receptor can activate the Rho/Rho kinase
pathway directly64 and may be involved in vascular
smooth muscle contraction via Rho-kinase.65 IGF-1
has been reported to induce a slowly developing
sustained contraction, which was dependent on Rho-
kinase, since contraction was almost completely
inhibited by (+)-I-trans-4-(1-aminoethyl)-N-(4-pyridyl)
cyclohexane carboxamide (Y-27632; 1 lmol L)1).66,67
It has also been demonstrated that IGF-1 increases
intracellular calcium concentration [Ca2+]i mediated
by protein kinase C-dependent pathways, which mod-
ulate [Ca2+]i through a Na
+/Ca2+-dependent trans-
porter. These intracellular signaling events have been
suggested to be required for mitogenic and contractile
actions of growth factors in vascular smooth muscle
cells. Diabetic cardiomyopathy is characterized by
impaired ventricular contraction and altered function
of IGF-I. It has been shown that impaired cardiac
excitation and contraction coupling in diabetes is
significantly improved by exogenous IGF-I administra-
tion, which has been proposed to be probably by
improved intracellular [Ca2+]i homeostasis. IGF-1-
induced cardiac contractile response was reduced with
advanced age. It has been recently shown that hyper-
tension and advanced age significantly attenuated
IGF-1-induced myocardial force generating capacity
indicating that IGF-1 may play a role in the altered
myocardial function under hypertension and/or
advanced age. The resistance to IGF-1 in hypertension
and advanced age may be due to alterations in nitric





Aging, oxidative stress and DNA damage
Elucidating the molecular mechanisms that underlie
the effects of physiological aging on organ and cellular
function is an area of intense investigation. Perhaps the
most frequently proposed mechanism underlying cel-
lular senescence is oxidative damage affecting the
nucleotide pool and biochemical pathways associated
with maintenance of cell structure and function.68 For
example, the DNA damage observed in senescent cells
has been attributed to elevated levels of reactive
oxygen species (ROS) and failing DNA damage repair
processes. The nucleotide pool appears to be a signif-
icant target for oxidants and oxidized nucleotides, once
incorporated into genomic DNA, can lead to the
induction of a DNA strand break-associated injury
that triggers senescence in normal cells. However, it
remains unclear how labile molecules such as ROS are
able to damage chromatin-bound DNA to a sufficient
extent to invoke persistent DNA damage and abnormal
cell-cycle signaling.
Epigenomics and aging
In addition to age-associated accumulation of damage
to the nucleotide pool, emerging evidence supports a
role for epigenetic mechanisms in cellular senes-
cence.69 Epigenetics refers to a set of potentially self-
perpetuating, covalent modifications of DNA and post-
translational modifications of nuclear proteins that can
produce lasting alterations in chromatin structure.
These mechanisms include methylation of DNA that
prevents gene transcription, acetylation of histone
proteins that promotes gene transcription and a robust
pool of endogenous microRNAs that regulate gene
transcription. These mechanisms can result in altera-
tions in specific patterns of gene expression that
ultimately affect the ability of aged cells to be ‘plastic’.
For example, genome-wide array analyses have impli-
cated cell-specific changes in histones, DNA methyl-
ation and regional relocation of RNAs as key processes
underlying age-related changes in neuronal functions
and synaptic plasticity.70 These experiments have
revealed evolutionarily conserved gene clusters associ-
ated with aging including apoptosis-, telomere- and
redox-dependent processes, insulin and estrogen sig-
naling and water channels.
Signal transduction pathways implicated in
regulating lifespan
Protein synthesis and degradation are regulated by
distinct genetic pathways that control aging in numer-
ous eukaryotic species. These highly conserved mech-
anisms include the insulin/IGF-1 (insulin-like growth
factor-1), TGF-I (transforming growth factor-beta), JNK
(c-Jun terminal kinase), RTK/Ras/MAPK (receptor
tyrosine kinase/Ras/mitogen-activated protein kinase)
and TOR (kinase target of rapamycin) signaling cas-
cades and the mitochondrial respiratory system that
promote protein synthesis, and the intracellular pro-
tein degradation machineries, including the ubiquitin-
proteasome system and lysosome-mediated auto-
phagy.71 Emerging evidence supports the existence of
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a complex intimate regulatory relationship between
mechanisms promoting protein synthesis and those
mediating protein degradation. Specifically, conditions
that favor protein synthesis can enhance the rate at
which damaged proteins accumulate. This may explain
why targeted genetic interventions and environmental
factors such as dietary restriction that reduce protein
synthesis can extend lifespan and increase resistance to
cellular stress in several experimental models of aging.
Aging and autophagy
Autophagy or cellular self-eating is a major pathway for
bulk degradation and recycling of damaged cytosolic
macromolecules and organelles including mitochon-
dria. Mitochondria play a pivotal role in energy
production via the oxidative phosphorylation pathway
and cell death via both extrinsic (cell-surface receptor
mediated) and intrinsic apoptotic pathways. Reactive
oxygen species (ROS) form as by-products of oxidative
phosphorylation and their accumulation can cause
mitochondrial damage. Dysfunctional mitochondria
accumulate in aged individuals and cell homeostasis
is maintained by removal of the damaged organelles by
autophagy.72 If this process is insufficient cell death
can occur via a process that may be distinct from
classic apoptosis.73
Genetic studies indicate that autophagy-related
genes (Atg) are required for lifespan extension in
several eukaryotic models (including yeast, nematodes,
flies, and mammals) exposed to prolonged nutrient
reduction. Promoting basal expression of Atg8 in
Drosophila in the nervous system extends lifespan by
50%.74 These observations support the emerging view
that autophagy may be a pivotal regulatory mechanism
for aging in eukaryotic species.75
Recent evidence suggests that SIRT1, a mammalian
homolog of SIR2 (silent information regulator 2) lon-
gevity factor, plays an important role in the regulation
of metabolism, cellular survival, and lifespan. Among
its functions SIRT1 appears to regulate the formation
of autophagic vacuoles, either directly or indirectly
through a downstream signaling network. The inter-
actions of SIRT1 with the forkhead transcription factor
(FoxO) and p53 signaling can also regulate both the
autophagic degradation and lifespan extension support-
ing a potential pivotal role for autophagy in the
regulation of lifespan.76
Another line of evidence supporting a key role for
autophagy in regulating longevity is data that inhibi-
tion of the mammalian target of rapamycin (mTOR)
significantly increases lifespan in several organisms
and observations that long-term treatment with rapa-
mycin, an inhibitor of the mTOR pathway77, or
ablation of the mTOR target p70S6K78 extends lifespan
in mice and may prevent congnitive deficits in a mouse
model of Alzheimer’s disease.79
The emerging role for cellular redox status and
aging
Cellular processes such as proliferation, differentiation
and death are intrinsically dependent upon the redox
status of a cell. Among markers of redox flux, cellular
NAD(H) levels play an important role in transcrip-
tional reprogramming. The interdependence of changes
in gene expression and NAD(H) is highly conserved
and viewed as crucial for the survival of a species
because of its role in determining reproductive capacity
and longevity.80 Proteins that bind and/or use NAD(H)
as a co-substrate (such as, CtBP and PARPs/Sirtuins,
respectively) are known to induce changes in chroma-
tin structure and transcriptional profiles. The ability of
these proteins to sense changes in NAD(H) levels has
been implicated in their roles in development, stress
responses, metabolic homeostasis, reproduction and
aging. It appears that the levels and activities of these
proteins, and the availability of NAD(H) are equally
important.
INTERVENTIONS THAT MAY REDUCE
THE EFFECTS OF AGING
A substantial body of evidence covering yeast to
humans indicates that dietary restriction is associated
with longer life expectancy compared to organisms fed
a normal or caloric rich diet.81 A similar effect is
observed when the activity of nutrient-sensing path-
ways is reduced by mutations or chemical inhibitors.
For example, in rodents, both dietary restriction and
decreased nutrient-sensing pathway activity can lower
the incidence of age-related loss of function and
disease, including tumors and neurodegeneration. Die-
tary restriction also increases life span and protects
against diabetes, cancer, and cardiovascular disease in
rhesus monkeys, and in humans it is associated with
changes that protect against these age-related changes.
It is noteworthy that tumors and diabetes are
also uncommon in humans with mutations in the
growth hormone receptor, and natural genetic variants
in nutrient-sensing pathways are associated with
increased human life span.
The composition of the diet is likely important. For
example, a recent study examined the effect of a
hypoproteic (8% protein vs 22% protein in controls)
diet on myenteric neurons in the Wistar rat.82
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Morphometric analysis of the nitrergic (NADH-diaph-
orase) positive myenteric neurons demonstrated a
larger number of small neurons and a smaller number
of medium neurons in the animals receiving the
hypoproteic chow, suggesting that the neuronal growth
was affected by the diet.
The specific nutrient-sensing pathways involved in
age-related diminution of function is an area of
intense investigation. As mentioned previously, target
of rapamycin (TOR) is an evolutionarily conserved
nutrient-sensing ser/thr protein kinase network that
regulates growth, metabolism and aging in eukaryotic
cells.83,84 Target of rapamycin is also emerging as a
robust mediator of the protective effects of various
forms of dietary restriction, which can extend life
span and slow the onset of certain age-related diseases
across species. Target of rapamycin signaling may
slow aging through downstream processes including
mRNA translation, autophagy, endoplasmic reticu-
lum (ER) stress signaling, stress responses, and metab-
olism.
Specific nutrients may have a protective effect on
age-related diminution in neural function via their
direct or indirect trophic actions. For example, poly-
unsaturated fatty acids (PUFA) of the omega-3 series
and omega-6 series stimulate neurite outgrowth in
immature DRG neurons obtained from male or female
rats. Recently, the effects of omega-3 PUFAs, particu-
larly docosahexanoic acid were shown to have a
marked effect on neurite outgrowth in DRGs from
aged (18–20 months) rats. These effects were compara-
ble to that of nerve growth factor and all-trans-retinoic
acid.85
Sialylated glycosphingolipids (i.e., gangliosides) and
glycoproteins play important roles in cell contact,
communication, and signaling processes and
decreased sialylation is observed in advanced age
and correlates with neurodegeneration.86 Feeding
aged rats a sialic acid-rich diet stimulated salivation
and subpopulations of colon enteric neurons.87
Specifically, the colonic expression of nNOS and
panneuronal marker UchL1 (PGP9.5) and the rate-
limiting enzyme for sialic acid synthesis GNE
[(glucosamine (UDP-N-acetyl)-2-epimerase/N-acetyl-
mannosamine kinase; E.C. 5.1.3.14)] were differen-
tially affected in young and aged rats by sialic acid
feeding. The UchL1 gene expression showed a
marked increase in aged control rats as compared to
young control rats which normalized in aged rats to
the level of young control rats. The nitrergic marker
nNOS showed a trend to increased expression in
old rats and sialic acid feeding strongly reduced
nNOS expression. In contrast, the expression of the
cholinergic neuron markers ACHE (acetylcholine
esterase), calbindin 1, and calbindin 2 were neither
affected by age nor sialic acid feeding.
A novel potential target for the development of anti-
aging drugs is the SIR2 family of NAD-dependent
deacetylases/ADP-ribosyltransferases, called ‘sirtuins.’
Sirtuins regulate many fundamental biological pro-
cesses in response to a variety of environmental and
nutritional stimuli. The mammalian SIR2 ortholog
SIRT1 has received attention recently, and small
molecule SIRT1 activators (STACs), including the
plant-derived polyphenolic compound resveratrol, have
been developed.88 Sirtuin activity is also regulated by
NAD biosynthetic pathways, and nicotinamide phos-
phoribosyltransferase (NAMPT) plays a critical role in
the regulation of mammalian sirtuin activity. Recent
studies have provided a proof of concept that nicotin-
amide mononucleotide (NMN), the NAMPT reaction
product, can be used as a nutriceutical to activate
SIRT1 activity and, thereby, modulate longevity
pathways. 88
SUMMARY
Understanding the effects of aging on the gut neuro-
muscular axis is of growing and profound importance
in light of demographic data demonstrating a steady
increase in the aged population globally. Likely areas of
significant importance include the potential effects of
aging on the extrinsic and intrinsic innervations,
smooth muscle function in the human colon, and
determination of whether specific biomarkers can be
identified in the gut neural plexi, ICC, glial cells or
smooth muscle that predict the onset of neurodegen-
eration. Age-related neuronal losses occur in both the
myenteric plexus and submucosal plexus. In general,
these losses start in adulthood and progress during the
lifespan and involve cholinergic neurons predomi-
nately. Parallel age-dependent loss of enteric glia is
also observed. The drop-out of these cell populations
follows an oral-anal gradient, with greater losses noted
distally. Dystrophic axonal swelling and dilated vari-
cosities also increase in an age-dependent manner in
the extrinsic innervations (vagal, DRG and sympa-
thetic pathways), as well as, nitrergic neurons in the
gut.
Advanced age is associated with increased oxidative
stress and mitochondrial dysfunction at the cellular
level, culminating in disequilibrium between cytopro-
tective and cytotoxic pathways favoring the latter.
Caloric restriction and/or diets supplemented with
specific nutrients may help attenuate the effects of
aging on neuromuscular function.
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